These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26362473)

  • 1. C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention.
    Calderón-Cruz B; Rodríguez-Galván K; Manzo-Francisco LA; Vargas-Alarcón G; Fragoso JM; Peña-Duque MA; Reyes-Gómez CA; Martínez-Ríos MA; De la Peña-Díaz A
    Thromb Res; 2015 Nov; 136(5):894-8. PubMed ID: 26362473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome].
    Zhou CF; Ren YH; Song YQ; Yi J; Han BS; Xue Q; Fu ZH; Li DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):309-14. PubMed ID: 27112608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
    Jaitner J; Morath T; Byrne RA; Braun S; Gebhard D; Bernlochner I; Schulz S; Mehilli J; Schömig A; Koch W; Kastrati A; Sibbing D
    Circ Cardiovasc Interv; 2012 Feb; 5(1):82-8, S1-2. PubMed ID: 22298798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of common ABCB1 polymorphism on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites.
    Karaźniewicz-Łada M; Danielak D; Rubiś B; Burchardt P; Komosa A; Lesiak M; Główka F
    J Clin Pharm Ther; 2015 Apr; 40(2):226-31. PubMed ID: 25430046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
    Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome.
    Campo G; Parrinello G; Ferraresi P; Lunghi B; Tebaldi M; Miccoli M; Marchesini J; Bernardi F; Ferrari R; Valgimigli M
    J Am Coll Cardiol; 2011 Jun; 57(25):2474-83. PubMed ID: 21679849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population.
    Isordia-Salas I; Olalde-Román MJ; Santiago-Germán D; de la Peña NC; Valencia-Sánchez JS
    Thromb Res; 2012 Sep; 130(3):e67-72. PubMed ID: 22819265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the
    Biswas M; Rahaman S; Biswas TK; Ibrahim B
    Expert Opin Drug Saf; 2020 Dec; 19(12):1605-1616. PubMed ID: 33040624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation.
    Galić E; Vrbanić L; Kapitanović S; Catela Ivković T; Petro D; Vuković I; Bsharat RS; Milicević Z; Vcev A; Mirat J
    Coll Antropol; 2013 Jun; 37(2):491-8. PubMed ID: 23940995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
    Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
    Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention.
    Jeong YH; Tantry US; Park Y; Kwon TJ; Park JR; Hwang SJ; Bliden KP; Koh EH; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Diabetes Care; 2012 Nov; 35(11):2194-7. PubMed ID: 22837373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential clinical utility of genetic and platelet function tests in patients on treatment with clopidogrel.
    Cattaneo M
    J Cardiovasc Med (Hagerstown); 2013 Dec; 14 Suppl 1():S16-21. PubMed ID: 24378837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
    Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
    Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction.
    Zhang JH; Tang XF; Zhang Y; Wang J; Yao Y; Ma YL; Xu B; Gao RL; Gao Z; Chen J; Song L; Wu Y; Meng XM; Yuan JQ
    Thromb Res; 2014 Nov; 134(5):970-5. PubMed ID: 25217066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of on-clopidogrel high platelet reactivity.
    Campo G; Miccoli M; Tebaldi M; Marchesini J; Fileti L; Monti M; Valgimigli M; Ferrari R
    Platelets; 2011; 22(6):399-407. PubMed ID: 21627411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis.
    Su J; Xu J; Li X; Zhang H; Hu J; Fang R; Chen X
    PLoS One; 2012; 7(10):e46366. PubMed ID: 23056288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
    Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
    Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention.
    Phankingthongkum R; Panchavinnin P; Chinthammitr Y; Tresukosol D; Chotinaiwattarakul C; Tungsubutra W; Wongpraparut N; Kitrattana B; Leewanun P
    J Med Assoc Thai; 2013 May; 96(5):538-43. PubMed ID: 23745307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.
    Diehl P; Olivier C; Halscheid C; Helbing T; Bode C; Moser M
    Basic Res Cardiol; 2010 May; 105(3):379-87. PubMed ID: 19943165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified clopidogrel loading dose according to platelet reactivity monitoring in patients carrying ABCB1 variant alleles in patients with clopidogrel resistance.
    Wang XD; Zhang DF; Liu XB; Lai Y; Qi WG; Luo Y; Hu B; Yao YA
    Eur J Intern Med; 2012 Jan; 23(1):48-53. PubMed ID: 22153531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.